These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

150 related articles for article (PubMed ID: 7053814)

  • 1. Myosarcomas of the stomach: natural history, prognostic factors and management.
    Shiu MH; Farr GH; Papachristou DN; Hajdu SI
    Cancer; 1982 Jan; 49(1):177-87. PubMed ID: 7053814
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Results of aggressive treatment of gastric sarcoma.
    Carson W; Karakousis C; Douglass H; Rao U; Palmer ML
    Ann Surg Oncol; 1994 May; 1(3):244-51. PubMed ID: 7531105
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Myosarcomas of the small and large intestine: a clinicopathologic study.
    Shiu MH; Farr GH; Egeli RA; Quan SH; Hajdu SI
    J Surg Oncol; 1983 Sep; 24(1):67-72. PubMed ID: 6887940
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Malignant leiomyoblastoma of the stomach (epithelioid leiomyosarcoma)].
    Galifer RB; Margueritte G; Barneon G; Bosc O; Couture A; Rieu D
    Chir Pediatr; 1987; 28(2):120-4. PubMed ID: 3621389
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Clinical study of 76 cases of smooth muscle tumor of the stomach].
    Yuasa N; Takagi K; Ota H; Nishi M; Yanagisawa A
    Nihon Geka Gakkai Zasshi; 1992 Mar; 93(3):248-56. PubMed ID: 1513306
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Surgical treatment of soft tissue tumors of the stomach.
    Lehnert T; Sinn HP; Waldherr R; Herfarth C
    Eur J Surg Oncol; 1990 Aug; 16(4):352-9. PubMed ID: 2379593
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Gastric leiomyosarcoma. Prognostic factors and surgical management.
    Grant CS; Kim CH; Farrugia G; Zinsmeister A; Goellner JR
    Arch Surg; 1991 Aug; 126(8):985-9; discussion 989-90. PubMed ID: 1863217
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Gastrointestinal sarcomas. Analysis of prognostic factors.
    McGrath PC; Neifeld JP; Lawrence W; Kay S; Horsley JS; Parker GA
    Ann Surg; 1987 Dec; 206(6):706-10. PubMed ID: 3689007
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prognostic Factors for Survival in Node-Negative Gastric Cancer Patients Who Underwent Curative Resection.
    Zhou Y; Cui JG; Huang F; Zhang A; Li C; Zhao ZC; Li WD; Fu WH
    Scand J Surg; 2017 Sep; 106(3):235-240. PubMed ID: 28376652
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Gastric leiomyosarcoma: a clinicopathologic study.
    Abbas JS; Massad M; Mufarrij A; Saksouk F; Kulaylat M
    Int Surg; 1986; 71(3):176-81. PubMed ID: 3771120
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Changes in postoperative recurrence and prognostic risk factors for patients with gastric cancer who underwent curative gastric resection during different time periods.
    Kim DH; Kim SM; Hyun JK; Choi MG; Noh JH; Sohn TS; Bae JM; Kim S
    Ann Surg Oncol; 2013 Jul; 20(7):2317-27. PubMed ID: 23677605
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prognosis of curatively resected pT4b gastric cancer with respect to invaded organ type.
    Min JS; Jin SH; Park S; Kim SB; Bang HY; Lee JI
    Ann Surg Oncol; 2012 Feb; 19(2):494-501. PubMed ID: 21837527
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prognostic factors and recurrence pattern in node-negative advanced gastric cancer.
    Lee IS; Yook JH; Kim TH; Kim HS; Kim KC; Oh ST; Kim BS
    Eur J Surg Oncol; 2013 Feb; 39(2):136-40. PubMed ID: 23148932
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Clinicopathologic study of primary malignant gastrointestinal stromal tumor of the stomach, with special reference to prognostic factors: analysis of results in 140 surgically resected patients.
    Fujimoto Y; Nakanishi Y; Yoshimura K; Shimoda T
    Gastric Cancer; 2003; 6(1):39-48. PubMed ID: 12673425
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Influence of Prognostic Factors for Recurrence of Adenocarcinoma of the Stomach.
    Mehmedagic I; Hasukic S; Agic M; Kadric N; Hasukic I
    Med Arch; 2016 Dec; 70(6):441-444. PubMed ID: 28210017
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Extended multiorgan resection for T4 gastric carcinoma: 25-year experience.
    Carboni F; Lepiane P; Santoro R; Lorusso R; Mancini P; Sperduti I; Carlini M; Santoro E
    J Surg Oncol; 2005 May; 90(2):95-100. PubMed ID: 15844189
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Effect of lymphatic vascular invasion on the prognosis of stage I( gastric cancer patients after radical gastrectomy].
    Shang L; Li B; He F; Li Y; Li J; Zhao Q; Li M
    Zhonghua Wei Chang Wai Ke Za Zhi; 2018 Feb; 21(2):175-179. PubMed ID: 29492916
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Clinicopathological study of gastric leiomyogenic tumors.
    Yamagiwa H; Matsuzaki O; Ishihara A; Yoshimura H
    Gastroenterol Jpn; 1978; 13(4):272-80. PubMed ID: 710823
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prognostic significance of distal subtotal gastrectomy with standard D2 and extended D2 lymphadenectomy for locally advanced gastric cancer.
    Zhang CD; Shen MY; Zhang JK; Ning FL; Zhou BS; Dai DQ
    Sci Rep; 2015 Nov; 5():17273. PubMed ID: 26602830
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A multifactorial approach for the prognosis of patients with carcinoma of the stomach after curative resection.
    Bozzetti F; Bonfanti G; Morabito A; Bufalino R; Menotti V; Andreola S; Doci R; Gennari L
    Surg Gynecol Obstet; 1986 Mar; 162(3):229-34. PubMed ID: 3952614
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.